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Abstract
Background: During embryogenesis, tight regulation of retinoic acid (RA) availability is fundamental for normal
development. In parallel to RA synthesis, a negative feedback loop controlled by RA catabolizing enzymes of the
cytochrome P450 subfamily 26 (CYP26) is crucial. In vertebrates, the functions of the three CYP26 enzymes
(CYP26A1, CYP26B1, and CYP26C1) have been well characterized. By contrast, outside vertebrates, little is known
about CYP26 complements and their biological roles. In an effort to characterize the evolutionary diversification of
RA catabolism, we studied the CYP26 genes of the cephalochordate amphioxus (Branchiostoma lanceolatum), a
basal chordate with a vertebrate-like genome that has not undergone the massive, large-scale duplications of
vertebrates.
Results: In the present study, we found that amphioxus also possess three CYP26 genes (CYP26-1, CYP26-2, and
CYP26-3) that are clustered in the genome and originated by lineage-specific duplication. The amphioxus CYP26
cluster thus represents a useful model to assess adaptive evolutionary changes of the RA signaling system following
gene duplication. The characterization of amphioxus CYP26 expression, function, and regulation by RA signaling
demonstrated that, despite the independent origins of CYP26 duplicates in amphioxus and vertebrates, they
convergently assume two main roles during development: RA-dependent patterning and protection against
fluctuations of RA levels. Our analysis suggested that in amphioxus RA-dependent patterning is sustained by CYP26-
2, while RA homeostasis is mediated by CYP26-1 and CYP26-3. Furthermore, comparisons of the regulatory regions
of CYP26 genes of different bilaterian animals indicated that a CYP26-driven negative feedback system was present
in the last common ancestor of deuterostomes, but not in that of bilaterians.
Conclusions: Altogether, this work reveals the evolutionary origins of the RA-dependent regulation of CYP26 genes
and highlights convergent functions for CYP26 enzymes that originated by independent duplication events, hence
establishing a novel selective mechanism for the genomic retention of gene duplicates.
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Background
During animal development, the vitamin A-derived mor-
phogen retinoic acid (RA) mediates a number of crucial
functions, including, for example, early embryonic pat-
terning and organogenesis, by acting on different cellular
processes ranging from proliferation to cell death [1–7].
In vertebrates, normal development requires a very
tightly controlled balance of the total amount of avail-
able RA, which is maintained through positive and nega-
tive feedback loops associated, respectively, with RA
production (chiefly by RALDH1, 2, and 3, for retinalde-
hyde dehydrogenase 1, 2, and 3) and RA degradation
(chiefly by CYP26A1, B1, and C1, for cytochrome P450
subfamily 26A1, B1, and C1) [8–12]. The biological re-
sponse to endogenous RA, in turn, is mediated by het-
erodimers of two nuclear receptors, the retinoic acid
receptor (RAR) and the retinoid X receptor (RXR), with
the expression levels of RAR in particular being tightly
linked to the availability of RA [1, 3, 4]. RAR/RXR het-
erodimers directly exert their transcriptional function by
binding to RA response elements (RAREs) in the regula-
tory regions of RA target genes [13]. A typical RARE is
composed of two direct repeats (DRs) corresponding to
a conserved nucleotide sequence [(A/G)G(G/T)TCA]
separated by a spacer composed of one, two or five nu-
cleotides (corresponding to, respectively, DR1, DR2, and
DR5 elements) [13–15]. Upon RA binding, RAR/RXR
heterodimers generally function as ligand-activated tran-
scription factors, but can also mediate RA-dependent re-
pression of target genes in a context-specific manner,
the exact molecular modalities of which still remain to
be established [16].
During vertebrate development, the RA degrading en-
zymes of the CYP26 subfamily play critical roles in the
formation of an anterior-posterior (A-P) RA gradient as
well as in the compensation of RA level fluctuations by
oxidizing RA into biologically inactive compounds [17].
They are thus characterized by dynamic, yet highly spe-
cific, developmental expression patterns in vertebrates
[18], with CYP26A1, for example, being expressed in the
anterior ectoderm in the early embryo and subsequently
becoming localized, amongst other tissues, to the hind-
brain, the pharyngeal arches, and the tail bud. Similarly,
both CYP26B1 and CYP26C1 are detectable in specific
rhombomeres of the hindbrain and in pharyngeal arches
as well as in fin and limb buds of the developing embryo
[18]. Concomitantly, the loss of CYP26 function has been
associated both with A-P patterning defects, most prom-
inently in the developing central nervous system (CNS)
and the mesoderm, and an increased sensitivity to RA
teratogenicity [19]. For instance, CYP26A1 knockout mice
are characterized by a posteriorization of the hindbrain
and the vertebral column, and CYP26B1 genetic ablation
leads to craniofacial and limb malformations [20].
Interestingly, while the loss of CYP26C1 alone does not
result in overt anatomical abnormalities [21], the com-
bined removal of CYP26C1 with either CYP26A1 or
CYP26B1 induces phenotypes that are more severe than
those aforementioned, thereby suggesting that CYP26C1
plays an important cooperative role in the CYP26-
mediated control of endogenous RA levels during verte-
brate development [19, 21].
In line with this cooperative action of CYP26 enzymes,
the vertebrate RA signaling system in general is charac-
terized by complex feedback mechanisms that are
mediated, either indirectly or directly, by RAR/RXR-
dependent signaling. As an example of an indirect regu-
lation, it has been shown that, in the vertebrate trunk,
RA, generated by RALDH activity, represses and con-
fines FGF8 expression to rostral and caudal domains (i.e.
to the heart- and tail bud-associated progenitor fields)
[16]. This action is mediated by RAR/RXR heterodimers
binding to a repressive DR2 RARE located upstream of
the FGF8 gene [22, 23] that, in turn, activates CYP26 ex-
pression both anteriorly and posteriorly to limit the ex-
tent of RA activity [16, 24, 25]. In addition, the
expression of CYP26A1 and CYP26B1 have been shown
to be dependent on RA activity, thereby generating a
CYP26-controlled negative feedback loop in RA sensitive
tissues to reduce the overall amount of available RA [9,
18, 26, 27]. For CYP26A1, this regulation is directly me-
diated by RAR/RXR heterodimers binding to DR5
RAREs in the promoter region, while for CYP26B1 this
control seems to be indirect [26, 27]. Note further that
the vertebrate CYP26C1 gene is likely to contribute dif-
ferently than its paralogs to this negative feedback sys-
tem, as CYP26C1 expression is actually downregulated
following RA stimulation [9].
The intricate molecular mechanisms controlling the ca-
tabolism of endogenous RA during vertebrate development
likely arose at the base of this lineage following the whole
genome duplication (WGD) events that took place during
early vertebrate diversification [28, 29]. Therefore, the evo-
lutionary elaboration of the RA signaling system in general
seems to be tightly linked to the duplication of RA metab-
olism genes. The so-called DDC model (for Duplication-
Degeneration-Complementation) predicts three possible
outcomes following duplication of a gene: non-
functionalization (i.e. the loss of one of the duplicates), neo-
functionalization (i.e. one of the copies retains the ancestral
role, while the other duplicate assumes a novel functional-
ity) or sub-functionalization (i.e. both duplicates assume a
part of the function of the single ancestral gene) [30, 31].
While the model predicts that the most likely outcome fol-
lowing duplication of a gene is the loss of one of the dupli-
cates (i.e. non-functionalization), very clear examples for
the neo-functionalization and the sub-functionalization of
duplicated genes remain scarce [32, 33].
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In order to develop a credible scenario for the evolu-
tionary diversification of the vertebrate RA system and
investigate the implications of the DDC model in the
duplication of RA metabolism genes, we decided to
study the function and regulation of RA degradation
during embryonic development of the cephalochordate
amphioxus (Branchiostoma lanceolatum). Due to its
phylogenetic position at the base of chordates, amphi-
oxus is a very useful model to characterize chordate-
and vertebrate-specific innovations, both on a morpho-
logical and a genomic level. For instance, at the morpho-
logical level, amphioxus and vertebrates share a dorsal
CNS, a postanal tail as well as pharyngeal gill slits [34,
35], while, conversely, amphioxus lacks some vertebrate-
specific characters, such as definitive neural crest and
placodes as well as a cartilaginous or bony skeleton [34,
35]. Furthermore, amphioxus is a basal chordate that did
not undergo WGD [36, 37] and that possesses a
vertebrate-like RA signaling pathway [29, 36]. Thus,
while RA signaling in vertebrates is generally controlled
by three RARs (RARα, RARβ, RARγ) and three RXRs
(RXRα, RXRβ, RXRγ) that form a multitude of different
heterodimers, the amphioxus genome contains only one
RAR and one RXR gene [38]. Nevertheless, administra-
tion of exogenous RA during amphioxus gastrulation
leads, as observed in vertebrates, to the posteriorization
of the amphioxus CNS and endoderm, hence preventing,
for example, the formation of mouth and gill slits [38–
43]. These regionalization defects are further associated
with a deregulation of RAR and Hox gene expression,
which have been shown to be direct targets of RA sig-
naling in amphioxus, as they are in vertebrates [44].
In amphioxus, three CYP26 genes (CYP26-1, CYP26-2,
and CYP26-3) have been reported, which are clustered
together in the genome and have possibly emerged from
a lineage-specific duplication [29]. This CYP26 locus of-
fers a rare, if not unique, opportunity to investigate the
adaptive changes following lineage-specific duplication
that led to the retention of three CYP26 genes in the
genome. The results from our analyses thus show that
the three amphioxus CYP26 genes arose by lineage-
specific tandem duplication of a single, ancestral CYP26
gene. They further provide evidence that these three
genes assume two main functions during amphioxus de-
velopment, as they do in vertebrates, i.e. patterning of
the embryo and protection against RA level fluctuations.
These two roles have been sub-functionalized in amphi-
oxus with CYP26-2 mediating RA-dependent develop-
mental patterning and CYP26-1 and CYP26-3 assuming
the protection of the embryo from RA teratogenesis.
Moreover, the presence of functional RAREs in the
amphioxus CYP26 cluster indicates that RA degradation
is regulated in cephalochordates like in vertebrates, i.e.
directly by RAR/RXR heterodimers, hence establishing a
negative RA feedback system. Comparative genomic
analyses of CYP26 regulatory regions from different bila-
terian animals further suggest that this CYP26-
dependent negative RA feedback system is not unique to
chordates, but probably arose earlier in animal evolution
and was already present in the last common ancestor of
all deuterostomes, but not in that of all bilaterians. The
adaptive advantages of an elaborate CYP26-driven RA
degradation system are discussed. In sum, the evolution-
ary history of amphioxus CYP26 genes provides an ex-
cellent example for the sub-functionalization of two
distinct developmental functions and a paradigm for un-
derstanding the selective mechanisms acting on dupli-
cated genes and leading to their retention in the
genome.
Results
CYP26 genes were duplicated independently several
times in bilaterian evolution
Previous analyses have reported three CYP26 genes in
the Florida amphioxus, Branchiostoma floridae, and have
suggested that they likely originated by lineage-specific
duplication from a single ancestral CYP26 gene [29, 36].
Here, we have identified and cloned three CYP26 genes
from the European amphioxus, Branchiostoma lanceola-
tum. To further assess the phylogenetic relationships of
the amphioxus CYP26 genes relative to each other and
to other members of the CYP26 subfamily, thereby dis-
tinguishing between orthologous and paralogous CYP26
genes, we first carried out phylogenetic analyses using as
outgroup the CYP51 genes, which constitute the CYP
subfamily that is most closely related to the CYP26
genes [45]. For this phylogenetic tree reconstruction, we
used all CYP26 sequences from 15 vertebrates and 13 in-
vertebrates, including three cephalochordate species (B.
lanceolatum, B. floridae, and B. belcheri). Of note, while
we successfully identified genes encoding CYP26 in the
genomes of priapulids, brachiopods, mollusks, annelids,
sea urchins, hemichordates, cephalochordates, ascidian
tunicates, and vertebrates, we were unable to do so in
those of nematodes and arthropods (as previously re-
ported [2, 46]).
Within vertebrates, we found three CYP26 paralogs in
both cyclostomes (CYP26A1, CYP26B1/C1a, and
CYP26B1/C1b) and gnathostomes (CYP26A1, CYP26B1,
and CYP26C1). Multiple CYP26 paralogs were also iden-
tified in most invertebrates species studied (two in Capi-
tella teleta, Ciona intestinalis, Lottia gigantea, Priapulus
caudatus, and Saccoglossus kowalevskii, three in B. lan-
ceolatum, B. floridae, B. belcheri, Crassostrea gigas, and
Ptychodera flava, and four in Lingula anatina), with the
notable exceptions of the cephalopod Octopus bimacu-
loides and the sea urchin Strongylocentrotus purpuratus,
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each of which possesses only a single CYP26 gene
(Additional file 1).
The results of the phylogenetic analysis (Fig. 1 and
Additional file 2), obtained with both the Bayesian Infer-
ence (BI) and the Maximum Likelihood (ML) methods,
suggested an early phylogenetic separation of the
vertebrate CYP26A1 sequences from the vertebrate
CYP26B1/C1 sequences. Vertebrate CYP26A1 and
CYP26B1/C1 thus formed two independent clades
within the CYP26 subfamily, both of which being
strongly supported: 0,91/96 (posterior probability/boot-
strap percentage) for CYP26A1 and 1/99 for CYP26B1/
C1. Within these two vertebrate CYP26 clades, the
cyclostome sequences consistently branched at the base:
Lethenteron japonicum CYP26A1 at the base of the ver-
tebrate CYP26A1 (0,96/98) and CYP26B1/C1a and
CYP26B1/C1b from L. japonicum and Petromyzon mari-
nus at the base of the vertebrate CYP26B1/C1 (0,7/58).
Within the vertebrate CYP26B1/C1 clade, the associ-
ation of the gnathostome CYP26B1 sequences (0,73/58)
was less robustly supported than that of the
gnathostome CYP26C1 sequences (1/95), which might
be related to the presence of chondrichthyan-specific
CYP26B1 duplicates (CYP26B1 and CYP26B2 from Cal-
lorhinchus milii and Leucoraja erinacea) disrupting the
base of the CYP26B1 branch. Of note, while our analysis
revealed the general presence of CYP26A1, CYP26B1,
and CYP26C1 paralogs in chondrichthyans, we were un-
able to identify a CYP26A1 gene in C. milii and a
CYP26C1 gene in L. erinacea. Altogether, these data sug-
gest that the diversification of vertebrate CYP26 genes
was a highly complex process, involving WGD, lineage-
specific duplications as well as secondary gene losses.
Outside vertebrates, the CYP26 sequences from ecdy-
sozoans, ambulacrarians, and cephalochordates always
grouped together with very strong support values: the
ecdysozoan P. caudatus (1/100), the ambulacrarians P.
flava and S. kowalevskii (1/99), and the cephalochordates
B. lanceolatum, B. floridae and B. belcheri (1/99). Col-
lectively, these results suggest that, within each of these
invertebrate groups, the CYP26 gene complement origi-
nated independently by linage-specific duplication. In
contrast, the two sequences from the tunicate C. intesti-
nalis did neither associate with each other, nor reliably
with one of the major CYP26 clades in the tree. It is
therefore impossible to comment on the nature and ori-
gin of the CYP26 duplication in this animal. Similarly,
the reconstruction of the evolutionary history of lopho-
trochozoan CYP26 genes is complicated by the lack of
phylogenetic resolution between the sequences from the
five analyzed lophotrochozoan species, which formed an
unresolved polytomy in our analysis. Nonetheless, there
is evidence for lineage-specific duplications of CYP26
genes in the brachiopod L. anatina, which possesses
four CYP26 paralogs that established two distinct clades
in the tree, one very strongly (1/100) and one very
weakly (0,8/–) supported. Furthermore, two of the three
CYP26 sequences from the oyster C. gigas are grouped
within in a single clade, but the support for this associ-
ation is very weak (0,95/–). Future studies will thus have
to address the processes underlying the evolution of
lophotrochozoan CYP26 genes.
To gain further insights into the diversification of
CYP26 genes in different animal lineages, we next con-
ducted a phylogenetic dating analysis (Additional file 3).
This survey indicated that the CYP26 genes of the ecdy-
sozan P. caudatus were likely duplicated independently
at the end of the Ordovician (about 446 Mya). Similarly,
within the ambulacrarians, we found evidence for linage-
specific duplications in hemichordates, which likely oc-
curred during two different periods: the early Carbon-
iferous for S. kowalevskii (about 342 Mya) and the
middle Triassic for P. flava (about 240 Mya). Finally, in
chordate lineages, CYP26 genes have also likely been du-








































































Fig. 1 Phylogenetic analysis of the CYP26 subfamily. Diagrammatic
summary of Bayesian Inference (BI) and Maximum Likelihood (ML)
analyses of the phylogenetic relationships within the CYP26
subfamily, with CYP51 used as outgroup. The detailed tree is shown
in Additional file 2 and sequence information is given in Additional
file 1. Branch lengths are representative of the amino acid
substitution rate and branch support is indicated at each major
node as posterior probabilities (PP) for the BI tree and as bootstrap
percentages for the ML tree. Furthermore, the total number of
sequences (seq.) and species (sp.) is provided for the
CYP26 subfamily
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and vertebrates, with the three cephalochordate genes
resulting from an initial duplication in the early Carbon-
iferous (about 358 Mya), followed by a subsequent dupli-
cation during the middle Permian (about 295 Mya). In
contrast, while it is difficult to conclude on the timing of
the duplication giving rise to the two CYP26 genes in
the ascidian C. intestinalis, the evolution of the verte-
brate CYP26 complement is complex and implies a
series of duplications, including an ancient split into
CYP26A1 and CYP26B1/C1 and the subsequent diversi-
fication of CYP26A1, CYP26B1, and CYP26C1 during
the Cambrian period (about 548 to 510 Mya). It should
be added that, consistent with the results of the phylo-
genetic tree, the dating analysis did not yield reliable in-
formation on the timing of the duplications of
lophotrochozoan CYP26 genes.
CYP26-2 expression is suggestive of a function in
developmental patterning of the B. lanceolatum embryo
In vertebrates, CYP26A1, CYP26B1, and CYP26C1 have
very distinct expression patterns with several key do-
mains being conserved between different species [6, 18].
Thus, we next assessed the temporal and spatial
distribution of the three cephalochordate-specific dupli-
cates in the amphioxus B. lanceolatum by in situ
hybridization (ISH). The ISH results revealed that the
expression profiles of CYP26-1 and CYP26-3 are gener-
ally quite similar (Fig. 2a-e, t-x). For both genes, no sig-
nal was detectable by ISH from fertilization through mid
gastrulation. Expression of both CYP26-1 and CYP26-3
is first identifiable at late gastrula stages as a weak signal
in the lateral anterior mesoderm (Fig. 2a, b, t and u). As
development proceeds, this domain becomes associated
with the most anterior somites at mid neurula stage
(Fig. 2c, d, v and w). At this stage, CYP26-1 and CYP26-
3 are also discreetly and transiently expressed in the an-
terior central nervous system (CNS), at the level of the
first somite (Fig. 2c and v). Expression of both genes re-
mains very weak and chiefly associated with mesodermal
tissues during subsequent developmental stages (Fig. 2e
and x): while the CYP26-1 signal is most evident in cen-
tral and posterior regions of the larva (Fig. 2e), CYP26-3
is mainly detectable in central and more anterior larval
territories (Fig. 2x).
In contrast to CYP26-1 and CYP26-3, CYP26-2 has a
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Fig. 2 Developmental expression patterns of amphioxus CYP26 genes. Whole mount in situ hybridization experiments were carried out for CYP26-
1 (a-e), CYP26-2 (f-s), and CYP26-3 (t-x). Amphioxus (Branchiostoma lanceolatum) embryos and larvae are shown as lateral views with anterior to
the left and the dorsal side up, excepting for (b, d, h, j, u, w), which are dorsal views (d.v.) with anterior to the left, and for (k-m) and (o-r),
which are cross-sections viewed from the front. Cross-sections in (k-m) are through the embryo shown in (i, j) at the levels indicated by the
dashed lines and cross-sections in (o-r) are through the embryo shown in (n) at the levels indicated by the dashed lines. White asterisks in (a, b,
t, u) highlight inconspicuous early expression domains of CYP26-1 and CYP26-3. Arrowheads in (c, v) indicate central nervous system expression
and in (k-m, q) ectodermal signal. Developmental stages shown are: early gastrula (f), late gastrula (a, b, g, h, t, u), mid neurula (c, d, i-m, v, w),
very early larva (n-r), early (60 h) larva (e, s, x). Scale bars are 100 μm for the whole mounts and 50 μm for the cross-sections
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during B. lanceolatum embryonic and early larval devel-
opment. Expression of CYP26-2 is first detectable by
ISH at the mid gastrula stage with the signal being local-
ized globally around the blastopore (Fig. 2f ). The
blastopore-associated signal subsequently weakens and,
at the late gastrula stage, an additional expression do-
main appears in a region corresponding to presumptive
lateral mesoderm and anterior neuroectoderm (Fig. 2g
and h). By the mid neurula stage, the mesodermal signal
has been expanded into the two anterior-most somite
pairs (Fig. 2i, j and l). At this stage, CYP26-2 is further
still detectable in the anterior neuroectodem (Fig. 2i, j
and l). Additionally, the gene is now expressed in the
ectoderm, most conspicuously in the anterior and pos-
terior tips of the embryo (Fig. 2i, j and k-m), as well as
in the anterior- and posterior-most endoderm (Fig. 2i, j
and m). At the mid neurula stage, the blastopore-
associated signal becomes perceivable in the newly
formed tail bud (Fig. 2f-j and m). In very early larvae,
just before the opening of the larval mouth, expression
of CYP26-2 is detectable anteriorly in all germ layers, i.e.
the ectoderm, the mesoderm, the endoderm as well as in
the CNS, with the signal being least noticeable in the
endoderm (Fig. 2n-p). Furthermore, in both ectoderm
and CNS, individual cells are labeled along the A-P body
axis (Fig. 2n and q) and, at the posterior end of the em-
bryo, the tail ectoderm strongly expresses CYP26-2
(Fig. 2n and r). In the amphioxus larva, the overall do-
mains of CYP26-2 expression are maintained, with con-
spicuous labeling anteriorly and posteriorly and a
weaker signal in the center (Fig. 2s). In sum, while
CYP26-1 and CYP26-3 expression is very discreet and
chiefly limited to the mesoderm, that of CYP26-2 is de-
tectable in all germ layers and dynamically changes in
space and time throughout development.
CYP26 acts as a fine regulator of RA levels in the
patterning of the B. lanceolatum larval tail fin
Disruption of CYP26 activity causes very severe defects
during vertebrate development [18]. To determine the
role of CYP26 enzymes in the amphioxus embryo, we
subsequently disrupted endogenous RA degradation dur-
ing amphioxus development by treatments with the
CYP26-specific inhibitor R115866 [47, 48]. For compari-
sons, the R115866 treatments were carried out in paral-
lel to treatments with RA or with two different RAR
antagonists (BMS009 and BMS493). The capacity of
R115866 to inhibit endogenous RA degradation was
verified by double treatments of R115866 and BMS493.
The results obtained from these different pharmaco-
logical treatments of B. lanceolatum embryos are in
large agreement between each other and with previous
studies that characterized the roles of RA signaling in
amphioxus endoderm specification and pharyngeal
patterning [38–43]. Thus, while the downregulation of
RA signaling activity by RAR antagonists (1 μM of either
BMS009 or BMS493) resulted in an enlarged pharynx
and an expansion of pharyngeal structures (Fig. 3e and
f), the upregulation of endogenous RA signaling by
1 μM RA led to a shortening of the pharynx and the
malformation of pharyngeal structures (such as the
mouth and the gill slits) (Fig. 3b). Consistently, the local
upregulation of RA signaling by 0,5 μM R115866 yielded
similar results (Fig. 3c), and co-treatments of 0,5 μM
R115866 and 1 μM BMS493 led to an attenuation of the
severe phenotype induced by 0,5 μM R115866 alone
with at least a partial recovery of pharynx formation and
patterning (Fig. 3d).
Importantly, these pharmacology-based experiments
revealed a previously undescribed role of RA signaling
in developmental patterning of the amphioxus larval tail
fin, a finding that is consistent with localized expression
of CYP26-2 in the amphioxus tail fin ectoderm. At 60 h
of development, amphioxus larvae are characterized by
an ectodermal tail fin that is pointy in shape and on
average 130,2 μm long (Fig. 3a and g). When amphioxus
embryos were treated with RA at the gastrula stage, the
resulting tail fins of 60-h larvae are round and signifi-
cantly shorter. These effects were observable with ex-
ogenous treatments of both 0,1 μM and 1 μM RA
(Fig. 3b and g). Similar results were obtained with
R115866 treatments at 0,1 μM and 0,5 μM (Fig. 3c and
g). Conversely, RAR antagonist treatments, with either
BMS009 or BMS493, had the inverse effect: the tail fin
becomes pointier in shape and is slightly elongated
(Fig. 3e-g). Co-treatment of 0,5 μM R115866 with 1 μM
BMS493 led to a partial rescue of the tail fin phenotype
with an almost normal shape and a slight reduction of
the overall length (Fig. 3d and g).
It has previously been shown that the amphioxus larval
tail fin is composed of columnar epidermal cells that con-
tain a large ciliary rootlet [49, 50] and that RA signaling
promotes tail regression in late, pre-metamorphic B. flori-
dae larvae by downregulating the gene encoding the main
component of the ciliary rootlet: the protein Rootletin
[51]. However, the regulation of Rootletin expression by
RA signaling in the tail fin of early B. floridae larvae has
not yet been reported. Given the effects on early tail fin
formation we observed in B. lanceolatum in response to
the alteration of endogenous RA signaling levels, we de-
cided to investigate the patterns of Rootletin expression in
60-h B. lanceolatum larvae following the pharmacological
treatment regimes detailed above. As previously described
for late B. floridae larvae [51], Rootletin is expressed in the
basal compartment of the columnar tail fin cells in 60-h B.
lanceolatum larvae (Fig. 3h). At this developmental stage,
the gene is further detectable in a small number of lateral
ectodermal cells (Fig. 3h).
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While treatment with 0,1 μM RA resulted in a marked
reduction of Rootletin expression concomitant with an
apical compaction of the columnar tail fin cells (Fig. 3i),
1 μM RA very strongly restricted the Rootletin expres-
sion domain (Fig. 3j). The effect on tail fin development
of either 0,1 μM or 0,5 μM of the CYP26 inhibitor
R115866 was similar to that of exogenous RA and the
R115866-treated larvae were thus generally characterized
by a significant reduction of Rootletin expression (Fig. 3k
and l). The RAR antagonists BMS009 and BMS493 led
to an apical expansion of Rootletin expression as well as
to an increase of the overall length of the tail fin (Fig. 3m
and n). Furthermore, the RAR antagonist treatments in-
duced Rootletin expression in additional lateral ectoder-
mal cells not directly associated with the tail fin (Fig. 3m
and n). Intriguingly, while co-treatments of 0,5 μM
R115866 and 1 μM BMS493 restored a shortened tail fin
with almost normal shape, expression of Rootletin
remained expanded into the apical territory of the tail
fin and detectable in lateral ectodermal cells (Fig. 3o).
Altogether, these observations suggest that the formation
of the ectodermal tail fin in B. lanceolatum is dependent
of RA signaling, with CYP26-dependent degradation
playing an important role in fine tuning of endogenous
RA signaling levels to ensure proper tail fin outgrowth.
CYP26-1 and CYP26-3 are highly responsive to RA and
specifically upregulated to avoid teratogenic effects of RA
In vertebrates, CYP26 enzymes are known to function
locally to reduce RA levels hence protecting target tis-
sues from RA teratogenesis. In this context, the regula-
tion of CYP26 activity is mediated, at least in part, by
RA signaling, which very dynamically up- or down-
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Fig. 3 Effects of retinoic acid (RA) signaling alterations on the development of amphioxus. (a-f) Early amphioxus (Branchiostoma lanceolatum)
larvae at 60 h of development with anterior to the left and the dorsal side up are shown as maximal projections of confocal microscopy scans
displaying auto-fluorescence (in red) and Hoechst nuclear staining (in cyan). Magnifications of the tail region are boxed, with anterior to the left
and the dorsal side up. Scale bars are 100 μm for the larvae and 50 μm for the magnified tail fins. (g) Tail fin length measurements following
pharmacological treatments. The length of the tail fin of B. lanceolatum larvae at 60 h of development was measured, as indicated in the sche-
matics. The graph shows the tail fin lengths ± standard deviation, with n = 15, for the different treatment conditions indicated. Tail fin lengths that
are significantly different from the DMSO control are indicated as “*”, for a cutoff value of p = 0,005, and as “**”, for a cutoff value of p = 0,001. (h-
o) Rootletin expression in the tail fin of early B. lanceolatum larvae at 60 h of development, with anterior to the left and the dorsal side up. Arrow-
heads in (h, m-o) indicate expression in lateral ectodermal cells. Pharmacological treatments are as indicated. Scale bars are 100 μm
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context [18]. To obtain insights into the regulation of
CYP26 genes by RA signaling in B. lanceolatum, we per-
formed quantitative real time PCR (qPCR) analyses on
amphioxus embryos at two developmental stages (mid
neurula and early larva) that have been treated, at the
early gastrula stage, with either 1 μM RA or 1 μM of the
RAR antagonist BMS009. The qPCR experiments
assessed the changes in relative expression of the three
B. lanceolatum CYP26 genes normalized by RAR expres-
sion in control embryos (Fig. 4a and b).
Through these analyses, we found that the expression
levels of CYP26-1 and CYP26-3 in control embryos
were very low when compared to CYP26-2 (about 45,0
to 50,0 times less in mid neurulae and 2,5 to 5,0 times
less in early larvae) (Fig. 4a and b). RA treatments very
significantly increased the expression of both CYP26-1
and CYP26-3 at the mid neurula stage (an average of 28
and 352,6 fold, respectively), while CYP26-2 levels in-
creased merely by about 2,1 fold (Fig. 4a). In contrast,
when embryos were treated with the RAR antagonist
BMS009, CYP26-1 levels decreased by an average of
18,7 fold in mid neurulae, while the overall transcrip-
tion of CYP26-2 and CYP26-3 remained relatively un-
changed when compared to controls (a decrease of
about 1,1 fold for CYP26-2 and an increase of about 1,4
fold for CYP26-3) (Fig. 4a). In early larvae, RA treat-
ment also significantly increased the expression levels
of CYP26-1 and CYP26-3 (by an average of 5,2 and
102,6 fold, respectively), while that of CYP26-2 in-
creased only by about 1,6 fold (Fig. 4b). The RAR an-
tagonist BMS009 had the opposite effect and strongly
decreased CYP26-1 levels by about 123,0 fold and
CYP26-3 levels by an average of 5,8 fold (Fig. 4b). In





























































































































































































































































































Fig. 4 Quantitative changes of amphioxus CYP26 expression in response to retinoic acid (RA) signaling alterations. Expression of CYP26-1, CYP26-2,
and CYP26-3 in amphioxus (Branchiostoma lanceolatum) was assessed by quantitative real time PCR (qPCR) at two developmental stages (mid
neurula at 20 h of development and early larva at 48 h of development). RAR expression was also established and used as a normalized positive
control. (a) Relative normalized expression (left panel) and fold change of expression levels (right panel) at the mid neurula stage, using a Log2
scale. (b) Relative normalized expression (left panel) and fold change of expression levels (right panel) at the early larval stage, using a Log2 scale
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1,2 fold (Fig. 4b). These results indicate that, although
CYP26-2 is the amphioxus CYP26 gene most strongly
and broadly expressed during embryogenesis, CYP26-1
and CYP26-3 are much more reactive to alterations of
endogenous RA signaling levels.
Following this quantification, we next assessed, by
ISH, the developmental expression profiles of amphioxus
CYP26 genes upon RA signaling-altering pharmaco-
logical treatments. Using the same developmental stages
as for the qPCR analyses (mid neurulae and early larvae),
we found that the upregulation of CYP26-1 expression
upon RA treatment was not uniform (Fig. 5a-f ). At the
mid neurula stage, CYP26-1 was most strongly induced
in the anterior half of the embryo in all tissue layers (i.e.
in CNS, ectoderm, mesoderm, and endoderm), all along
the CNS as well as in the posterior tip of the embryo in
all tissue layers excepting the mesoderm (Fig. 5a and b).
In early larvae, the gene was upregulated in all tissue
layers of the anterior half of the animal, but largely un-
detectable posteriorly, except in a few cells in the ecto-
derm (Fig. 5d and e). As expected from the qPCR
experiments, expression of CYP26-1 in embryos and lar-
vae treated with the RAR antagonist BMS009 was very
inconspicuous, but, after an extended coloration step,
was nonetheless detectable in mesodermal tissues (Fig. 5c
and f).
Treatment effects were similar, but not identical, for
CYP26-2. At the mid neurula stage, RA strongly induced
CYP26-2 anteriorly and posteriorly in all tissue layers as
well as all along the CNS and ectoderm (Fig. 5h). How-
ever, following RA treatment, CYP26-2 expression was
more conspicuous anteriorly and posteriorly in the em-
bryo, when compared to that of CYP26-1. In contrast, in
early larvae the effects of RA treatments were less pro-
nounced for CYP26-2 than for CYP26-1. Chiefly, CYP26-
2 expression expanded slightly in the mesoderm and
ectoderm in the anterior half of the animal (Fig. 5k and
l). Of note, the reduction of CYP26-2 expression in the
anterior endoderm of RA-treated larvae was due to the
absence of pharyngeal structures normally expressing
the gene [43]. Treatments with the RAR antagonist
BMS009 generally weakened the CYP26-2 signal, most
noticeably in the CNS, the mesoderm, and both the an-
terior and posterior ectoderm (Fig. 5j and m).
Finally, the expression of CYP26-3 was also very
strongly expanded by RA at mid neurula and early larva
stages, even more strongly than that of CYP26-1 with a
general expansion of the staining observed throughout
the embryo at both stages (Fig. 5n and o). Following RA
treatment, expression of the gene was induced anteriorly
and posteriorly in all tissue layers, most conspicuously























Fig. 5 Spatial changes of amphioxus CYP26 expression in response to retinoic acid (RA) signaling alterations. Whole mount in situ hybridization
experiments were carried out for CYP26-1 (a-f), CYP26-2 (g-m), and CYP26-3 (n-s) on amphioxus (Branchiostoma lanceolatum) embryos treated at
the late blastula stage with either DMSO (as control), all-trans RA (1 μM) or RAR antagonist BMS009 (1 μM). The BMS009-treated embryo in (c) and
larva in (f) were subjected to an extended coloration period. Mid neurula embryos at 20 h of development (a-c, g-j, n-p) and early larvae at 48 h
of development (d-f, k-m, q-s) are shown as lateral views with anterior to the left and the dorsal side up. Scale bars are 100 μm
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mesoderm (Fig. 5n and o). By the early larval stage,
CYP26-3 remained generally upregulated throughout the
animal (Fig. 5q and r), which contrasts with a more re-
stricted distribution of CYP26-1 and CYP26-2 transcripts
at this stage of development in response to RA treat-
ments (Fig. 5e and l). In embryos and larvae treated with
the RAR antagonist BMS009, the CYP26-3 signal was
very weak and chiefly limited to mesodermal tissues
(Fig. 5p and s). Altogether, these results show that treat-
ments with RA and RAR antagonist induce similar, but
not identical, tissue-specific responses of amphioxus
CYP26-1, CYP26-2, and CYP26-3, thereby supporting
the notion that each one of the three CYP26 genes is re-
quired for a distinctive set of developmental functions.
RA regulates CYP26-1, CYP26-2, and CYP26-3 directly and
via evolutionary conserved functional RAREs present in
the CYP26 cluster
To assess, whether the observed effects of RA and RAR
antagonist on amphioxus CYP26 expression were medi-
ated directly by RAR/RXR heterodimers, we first carried
out pharmacological treatments in the presence of puro-
mycin, a compound that efficiently blocks de novo pro-
tein synthesis in developing amphioxus [44]. Amphioxus
mid neurulae were hence treated with puromycin for
5 min prior to adding RA or the RAR antagonist
BMS009. The embryos were then sampled 1 h later and,
following RNA extraction, the expression levels of
CYP26-1, CYP26-2, and CYP26-3 were determined by
qPCR (Fig. 6). The results showed that, in the presence
of puromycin, RA treatments significantly upregulated
expression of both CYP26-1 and CYP26-3 (by about 5,8
fold and 5,9 fold, respectively), while that of CYP26-2 in-
creased more modestly, by about 1,6 fold (Fig. 6). The
RAR antagonist BMS009 had the inverse effect, reducing
CYP26-1 and CYP26-3 levels by about 1,8 fold and 2,9
fold, respectively. In contrast, CYP26-2 expression stayed
relatively stable, decreasing only by about 1,1 fold (Fig. 6).
Altogether, these results are consistent with the effects
of RA pharmacology on the expression of CYP26 genes
described above. Furthermore, they indicate that the re-
sponses to RA and RAR antagonist treatments of all
three amphioxus CYP26 genes do not require de novo
protein synthesis, thereby implying that they must be
mediated directly by RAR/RXR protein heterodimers
present in the target tissues.
In order to obtain deeper insights into the mecha-
nisms of the direct regulation of CYP26-1, CYP26-2, and
CYP26-3 by RA signaling we then investigated the gen-
omic environment of CYP26 genes in the three amphi-
oxus species with available genomes: B. floridae [36, 37],
B. belcheri [52], and B. lanceolatum [53]. Our analyses
allowed us to reconstruct the entire genomic clusters for
the three amphioxus CYP26 genes, previously described
only for B. floridae [29] (Fig. 7). Although variable in
size (about 85 Kbp in B. floridae, 56 Kbp in B. belcheri,
and 79 Kbp in B. lanceolatum from the start codon of
CYP26-1 to the stop codon of CYP26-3), the order of
the three CYP26 genes within the continuous clusters is
conserved between the three amphioxus species, lending
further support to the notion that these genes originated
by tandem duplications from a single ancestral CYP26
gene at the base of the cephalochordates. Making use of


























































































































Fig. 6 Dynamics of amphioxus CYP26 gene expression following protein synthesis inhibition and retinoid treatments. Expression of CYP26-1,
CYP26-2, and CYP26-3 was assessed in amphioxus (Branchiostoma lanceolatum) by quantitative real time PCR (qPCR) at the mid neurula stage (at
20 h of development) following protein synthesis inhibition by puromycin treatment (200 μg/ml) at 19 h of development and subsequent
treatment with DMSO (as control), all-trans RA (1 μM) or RAR antagonist BMS009 (1 μM) for 1 h. Relative normalized expression (left panel) and
fold change of expression levels (right panel) relative to the controls are shown
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Fig. 7 Organization and distribution of conserved retinoic acid response elements (RAREs) in the amphioxus CYP26 cluster. (a) Schematic
representation of the experimentally verified amphioxus (Branchiostoma lanceolatum) CYP26-1, CYP26-2, and CYP26-3 gene sequences, including
the 5′ and 3′ untranslated regions (UTRs) and the exons of the coding region, as well as of the corresponding scaffolds of the B. lanceolatum
genome that cover the complete CYP26 cluster and thus also include intronic and intergenic regions. The names of the B. lanceolatum genome
scaffolds are indicated, as is their orientation relative to the CYP26 cluster (+/− strand). (b) Distribution of conserved amphioxus RAREs in the B.
lanceolatum CYP26 cluster. The orientation of each RARE is indicated relative to the CYP26 cluster (+/−). RAREs recognized and bound by the B.
lanceolatum RAR/RXR heterodimer in vitro are indicated in black, RAREs that do not associate with the B. lanceolatum RAR/RXR heterodimer in
vitro are shown in grey. The RARE sequences are given in Additional file 4 and the in vitro assays are shown in Fig. 8
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clusters, we further searched systematically for con-
served RAREs in the vicinity of the CYP26-1, CYP26-2,
and CYP26-3 genes. This in silico survey included a gen-
omic region encompassing 20 Kbp upstream of the
CYP26-1 start codon and 20 Kbp downstream of
CYP26-3 stop codon (Fig. 7). In total, we identified 38
candidate RAREs in B. floridae, 30 in B. belcheri, and 21
in B. lanceolatum. Of these, 16 RAREs were conserved
between all three amphioxus species, both in terms of
DR motif sequences and their relative position within
the CYP26 cluster (Fig. 7b and Additional file 4).
These conserved amphioxus CYP26 RAREs, i.e. 13
DR5, 1 DR2, and 2 DR3 elements, were subsequently
used in EMSA analyses to investigate their capacity, in
vitro, to interact with the B. lanceolatum RAR/RXR het-
erodimer. Note that, even though DR3 elements are not
considered as common RAREs, they were included in
this survey. The results showed that the DR2 element
and 12 of the 13 DR5 elements can be recognized and
bound by the B. lanceolatum RAR/RXR heterodimer
(Figs. 7b and 8), indicating that most of these RAREs
might be functional in vivo. Furthermore, the consensus
signature of the in vitro validated amphioxus DR5 ele-
ments [(A/G)G(G/T)T(C/G)A NNN(A/G)(A/C/G) (A/
G)G(G/T)(T/A)CA] is very similar to the classical verte-
brate DR5 signature [(A/G)G(G/T)TCA (N)5 (A/G)G(G/
T)TCA] (Additional file 4), suggesting that, as in verte-
brates [54, 55], amphioxus CYP26 genes are regulated
directly by RA signaling via RAREs located in close
vicinity of the open reading frames (ORFs).
Furthermore, comparisons of the conserved and vali-
dated amphioxus CYP26 RAREs with functional RAREs
associated with vertebrate CYP26 genes revealed that the
amphioxus DR5-6 sequence located upstream of CYP26-
2 (Fig. 7b and Additional file 4) is identical in sequence
to a DR5 RARE located upstream of vertebrate
CYP26A1 genes [AGTTCA (N)5 AGTTCA] [26, 54]. To
verify, whether this DR5 RARE motif is a chordate
innovation or an ancestral signature of bilaterian CYP26
genes, we screened the genomic regions surrounding
CYP26 genes in the annelid C. teleta, the mollusk L.
gigantea, the echinoderm S. purpuratus, the hemichord-
ate S. kowalevskii, and three vertebrates (Takifugu
rubripes, Mus musculus, and Homo sapiens). While no
DR5 RARE with a similar motif could be identified in
the annelid C. teleta and the mollusk L. gigantea, the
conserved DR5 RARE was recovered in all three verte-
brate species as well as in the hemichordate S. kowalevs-
kii. Intriguingly, in the echinoderm S. purpuratus,
instead of a DR5 RARE, we found a DR2 RARE with
two similar DR sequences [AGTTCA] in an inverse
orientation relative to the conserved DR5 RAREs in
other species (Table 1). Of note, the conserved amphi-
oxus DR5 RARE is located significantly further away
from the CYP26 start codon than in the other studied
species. Although the biological significance of this find-
ing still remains to be explored, these results nonetheless
suggest that the direct control of CYP26 expression by
RA signaling, mediated at least in part by a conserved
DR5 RARE, is an ancestral feature that was most likely
absent in the last common ancestor of all bilaterians and
that was thus only subsequently acquired at the base of
the deuterostomes.
Discussion
CYP26 genes and their evolutionary involvement in
RA-dependent A-P patterning in chordates
In this study, we assessed the developmental expression
patterns and the biological functions of the three CYP26
duplicates from the European amphioxus B. lanceolatum.
Globally, our results suggest a sub-functionalization of


















































































Fig. 8 In vitro validation of putative retinoic acid response elements
(RAREs) in the amphioxus CYP26 cluster. Using in vitro synthesized
Branchiostoma lanceolatum RAR and RXR proteins, the binding of
the cognate RAR/RXR heterodimer to putative RAREs identified in
the amphioxus CYP26 cluster was assessed. The mouse CYP26A1 DR5
sequence (R1) [26] (Table 1) was used as 32P-radiolabeled double-
stranded probe. The RXR and RAR lanes respectively contained only
in vitro synthesized RXR or RAR proteins, together with the radiolabeled
probe. The H20 (water) lane contained radiolabeled probe as well as
RAR and RXR proteins. The NS (non-specific) lane contained a non-
specific and unlabeled double-stranded DR element in 100-fold molar
excess relative to the radiolabeled probe as well as RAR and RXR pro-
tein. All other lanes contained one of the 16 putative amphioxus DR el-
ements (for nomenclature explanations see Fig. 7b) at 10-fold (left lane)
or 100-fold (right lane) molar excess, along with RAR and RXR protein
and the radiolabeled mouse R1 element, to test the binding specificity
of the putative amphioxus RAREs. A black asterisk indicates that a given
DR element can be recognized by the B. lanceolatum RAR/RXR heterodi-
mer, as it outcompetes binding to the mouse R1 element
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are characterized by weak and disperse expression pat-
terns, while CYP26-2 displays a dynamic, tissue-specific
pattern along the A-P axis. Considering that A-P pattern-
ing in early stages of amphioxus development is
dependent on RA signaling [42, 44], the expression profile
of CYP26-2, at very distinct positions along the A-P axis
of the gastrula and early neurula, is suggestive of a func-
tional role for this gene in this RA-dependent patterning
process. This notion is further supported by the results
obtained by pharmacological inhibition of CYP26 action
during gastrulation, which yielded embryos and larvae that
resemble those treated with exogenous RA, displaying se-
vere A-P patterning defects [43]. Thus, we propose that
CYP26 enzymes assume two main functions during
amphioxus development (Fig. 9), which are equivalent to
those observed in vertebrates: (1) the mediation of RA-
Table 1 Conserved retinoic acid response elements (RAREs) with the characteristic sequence signature AGTTCA(N)5AGTTCA
identified in the vicinity of bilaterian CYP26 genes
Species RARE name Orientation relative to the CYP26 gene Sequence (5′–3′) Upstream of Distance to start codon Reference
S.p. + AGTTCAATAGTTCA CYP26 2503 bp This study
S.k. - AGTTCATACCCAGTTCA CYP26a 137 bp This study
B.f. DR5-6 - AGTTCAACAAAAGTTCA CYP26-2 6405 bp This study
B.b. DR5-6 - AGTTCAACAAAAGTTCA CYP26-2 6740 bp This study
B.l. DR5-6 - AGTTCAACAAAAGTTCA CYP26-2 4083 bp This study
H.s. R1 - AGTTCACCCAAAGTTCA CYP26A1 132 bp [26]
M.m. R1 - AGTTCACCCAAAGTTCA CYP26A1 134 bp [26]
D.r. R1 - AGTTCACACAAAGTTCA CYP26A1 166 bp [26, 54]
R2 - AGTTCAAGGATAGTTCA CYP26A1 1963 bp
T.r. R1 - AGTTCATTCAAAGTTCA CYP26A1 103 bp This study
Species name abbreviations: B.b. Branchiostoma belcheri, B.f. Branchiostoma floridae, B.l. Branchiostoma lanceolatum, D.r. Danio rerio, H.s. Homo sapiens, M.m. Mus















































Fig. 9 Model for regulation and function of CYP26 genes in amphioxus. The position of the functionally validated retinoic acid response elements
(RAREs) within the amphioxus CYP26 cluster is indicated relative to the start codons of the three amphioxus CYP26 genes (CYP26-1, CYP26-2, and
CYP26-3). The relative expression of each of the genes is indicated during normal development (normal levels of RA and active RAR/RXR receptor
heterodimers) as well as during exposure to RA (high levels of RA and active RAR/RXR receptor heterodimers), hence highlighting the dominance
of CYP26-2 during normal development and the importance of CYP26-1 and CYP26-3 for protection against RA teratogenesis
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dependent developmental patterning and (2) the protec-
tion against fluctuations of RA levels. Due to its conspicu-
ous and tissue-specific expression during development, we
hypothesize that the former is mainly assumed by CYP26-
2, while the latter is dependent on the activity of CYP26-1
and CYP26-3.
During early development, the expression domains of
CYP26-2 along the A-P axis are inversely correlated with
those of Hox1 and HNF3-1, both of which are direct tar-
gets of RA signaling in amphioxus [44, 56]. The poster-
ior expression limit of CYP26-2 in anterior tissues thus
abuts the anterior border of both the Hox1 and HNF3-1
domains [44]. Concomitantly, the blastopore-associated
expression of CYP26-2 seems to delineate the posterior
limits of both Hox1 and HNF3-1 [44, 56]. Given that
RAR expression is ubiquitous during gastrulation [38],
the presence of CYP26-2 in defined domains along the
A-P axis might thus be crucial for the creation of RA
sinks to subdivide the developing embryo into zones
with and without active RA signaling. This is reminis-
cent of the conserved expression and function of
CYP26A1 during vertebrate gastrulation: CYP26A1 is
expressed in the anterior neural ectoderm and functions
to establish A-P boundaries in the developing CNS [18].
It does so by establishing an anterior sink for RA pro-
duced posteriorly in the paraxial mesoderm, hence creat-
ing a RA gradient along the A-P axis of the
neuroectoderm [57, 58].
By the mid neurula stage, the CYP26-2 signal is
present in the entire anterior CNS, with a posterior limit
at the boundary between the first and second somite.
This CYP26 expression is hence limited to a region
homologous to the vertebrate forebrain and midbrain
[59], which is considerably different from what is ob-
served in the vertebrate CNS, where CYP26 genes are
expressed in the developing hindbrain and are funda-
mental for its patterning along the A-P axis [18, 19]. In
the amphioxus hindbrain homolog, RA signaling medi-
ated by RAR/RXR has been shown to confer regional
identity along the A-P axis by controlling the collinear
expression of Hox genes [42]. However, our work sug-
gests that, in contrast to the situation in vertebrates, this
process does not involve the deployment of CYP26 genes
in the amphioxus hindbrain homolog. Thus, while the
early role for CYP26 in neural patterning was probably
already present in the last common ancestor of amphi-
oxus and vertebrates, a CYP26-dependent mechanism
for subsequent hindbrain regionalization probably
evolved in vertebrates, following the vertebrate-specific
CYP26 duplications.
Following neurulation, the three amphioxus CYP26
genes are expressed in anterior mesoderm, most notice-
ably in the anterior-most somites. This is intriguing, as
to date there is no convincing evidence for a
requirement of RA signaling in amphioxus mesoderm
development [41, 42, 60] and the inhibition of CYP26
function by pharmacological treatments does not yield a
mesodermal phenotype [43]. These observations raise an
important question: why are CYP26 genes expressed in
the anterior amphioxus mesoderm, as they are in verte-
brate head mesoderm [25], if they are not required for
A-P patterning of this tissue? We speculate that the con-
spicuous expression of CYP26 in the anterior somites is
an amphioxus innovation and is thus not comparable to
the role of CYP26 in the vertebrate head mesoderm. In-
stead, the CYP26 genes might function in the anterior
amphioxus mesoderm to establish a buffer zone between
the CNS dorsally and the pharynx ventrally, which re-
quire distinct RA signaling cues for A-P regionalization
[41, 42]. Although further analyses aiming, for example,
at the visualization of in vivo RA signaling levels [58]
will be required to test this hypothesis, it would none-
theless be interesting to assess, whether this mechanism
for separating two gradient-based A-P patterning sys-
tems is being used more widely during development of
small-sized embryos.
In the course of development, the blastopore-
associated expression of amphioxus CYP26-2 becomes
incorporated into the tail bud, a structure that, from the
neurula stage on, plays a central role in posterior elong-
ation of the embryo and larva and that is further charac-
terized by the expression of tissue-specific marker genes,
such as Wnt3 [61]. In vertebrates, both CYP26A1 and
Wnt3a are also co-expressed in the developing tail bud,
and CYP26A1 null mutants are characterized by a trun-
cated tail and a spatial expression of Wnt3a that is ab-
normally restricted towards the midline of the posterior
neural plate [62]. These observations suggest that, in the
vertebrate tail bud, CYP26A1 functions to keep RA
levels low to create a permissive environment required
for the posterior elongation of the embryo [16, 63]. In
contrast, in amphioxus, treatments with CYP26 inhibi-
tor, exogenous RA or the RAR antagonist BMS009 do
not affect expression of Wnt3 in the tail bud [41]. Im-
portantly, these pharmacological treatments, albeit af-
fecting tail fin development, also do not impact
posterior elongation of the developing embryo [39, 60].
Together, these findings support the notion that CYP26
function, and more generally the RA signaling system, is
not required for tail bud-driven body extension in
amphioxus and that this role for RA likely evolved in the
vertebrate lineage.
CYP26 activity is required for the development of the
amphioxus tail fin
Previous studies in the Florida amphioxus, B. floridae,
have shown that the administration of excess RA during
gastrulation results in a small anus [39] and that the
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continuous administration of RA to B. floridae larvae
leads to closure of the anus and regression of the tail fin
[51]. Our data on the European amphioxus, B. lanceola-
tum, are consistent with these previous findings and fur-
ther suggest that RA signaling is required for proper tail
fin outgrowth. Given that CYP26-2 is the only B. lanceo-
latum CYP26 gene expressed in the posterior ectoderm,
it is very likely responsible for fine-tuning endogenous
RA signaling levels in this territory.
The amphioxus tail fin is established by columnar epi-
dermal cells that contain a large ciliary rootlet [49, 50]
and it has previously been shown that RA promotes the
downregulation of a major component of this structure,
the protein Rootletin [51]. This downregulation in turn
is likely responsible for the induction of tail fin regres-
sion upon RA treatments in B. floridae larvae [51]. Our
results of RA and CYP26 inhibitor treatments in B. lan-
ceolatum are generally consistent with these previous
observations, although we identified a major difference
in the developmental timing of the involvement of RA
signaling in tail fin outgrowth between the two amphi-
oxus species. This fact is exemplified by the experimen-
tal setups required to obtain tail fin phenotypes. While
in B. floridae RA-dependent tail fin malformations can
only be obtained by continuous treatment of pre-
metamorphic larvae with 6–8 gill slits [51], changes in
tail fin morphology can be induced much earlier during
B. lanceolatum development by treating in the course of
gastrulation. This suggests that, albeit required for tail
fin outgrowth in both amphioxus species, the attenu-
ation of high RA signaling levels in the posterior ecto-
derm might take place earlier in B. lanceolatum than in
B. floridae development. It is possible that this develop-
mental difference is mediated by a delayed activation of
the expression of CYP26-2 in B. floridae relative to B.
lanceolatum, although additional work is required to
support this claim. Altogether, these results indicate that
amphioxus tail fin development requires low levels of
RA signaling, which are maintained by CYP26 activity.
When compared to the known functions of CYP26 in
vertebrates, where cells expressing CYP26 enzymes are
said to be effectively devoid of RA [63], amphioxus tail
fin outgrowth might represent a rare example of a devel-
opmental process, where CYP26 is deployed to merely
reduce, and not to completely eliminate, RA signaling
levels.
Amphioxus CYP26 genes are highly responsive RA
signaling targets
In vertebrates, it has been established that, in RA-
sensitive tissues, RA induces CYP26 to generate a nega-
tive feedback loop that reduces the overall amount of
available RA [18]. In mice, for example, expression of
both CYP26A1 and CYP26B1 is upregulated upon RA
treatment [9] and, at least for CYP26A1, this regulation
is directly mediated by RAR/RXR binding to RAREs in
the vicinity of the CYP26A1 gene [26]. In contrast, the
vertebrate CYP26C1 gene is likely not contributing to
this RA-dependent negative feedback system, as its ex-
pression is actually downregulated upon RA stimulation
[9]. The data presented here suggest that expression of
all three amphioxus CYP26 genes, which are lineage-
specific duplicates and located in a single cluster in the
genome, is positively regulated by RA signaling. Accord-
ingly, the transcriptional regulation of B. lanceolatum
CYP26-1, CYP26-2, and CYP26-3 is in all likelihood dir-
ectly mediated by RAR/RXR heterodimers, given that
one DR2-type sequence and 12 DR5-type elements
within the CYP26 cluster are recognized and bound by
the B. lanceolatum RAR/RXR heterodimer in vitro. Of
these 13 in vitro validated RAREs, four DR5 elements
are located around the CYP26-1 coding sequence, four
DR5 and one DR2 are found in proximity of CYP26-2,
and four DR5 elements are associated with the CYP26-3
gene. Although each of the three amphioxus CYP26
genes are likely to be directly regulated by RA signaling,
the specific arrangement of RAREs relative to the CYP26
ORFs nonetheless suggests that the expression of each
of the three genes is regulated independently by different
sets of RAREs. Although this fundamental difference in
the regulation of amphioxus and vertebrate CYP26 genes
remains to be demonstrated mechanistically in vivo, it is
nonetheless tempting to speculate that alterations in the
regulation by RA have been key for redefining the func-
tions of the different CYP26 genes following their dupli-
cation, hence leading to their genomic retention by sub-
functionalization.
At least some of the RAREs within the amphioxus
CYP26 cluster might serve as hubs for long-range regu-
lation of gene expression from shared RAREs. Although
in both amphioxus and vertebrates it has previously
been shown that functional RAREs are generally located
in the proximity of genes directly regulated by RA sig-
naling [16, 64], long-range regulatory mechanisms of RA
signaling have, for example, been implicated in the con-
trol of the rostral expansion of posterior Hoxb genes
during mouse CNS development [65]. The in vivo valid-
ation of the RAREs located within the amphioxus
CYP26 cluster will shed light on their contribution to
short- and/or long-range transcriptional control mecha-
nisms exerted by RA signaling. Our in silico analyses
further revealed the presence, within the amphioxus
CYP26 cluster, of two DR3 elements in close proximity
of one of the in vitro validated DR5 elements. Although
DR3 elements are generally not recognized by RAR/RXR
heterodimers, they are bound by other nuclear receptors,
such as vitamin D receptors [66]. The presence of DR3
elements within the amphioxus CYP26 cluster thus hints
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at the possibility that additional nuclear receptors are in-
volved in the regulation of amphioxus CYP26 genes.
Interestingly, the consensus sequence of the in vitro
validated amphioxus DR5 RAREs is identical to the clas-
sical vertebrate DR5 sequence consensus [(A/G)G(G/
T)TCA (N)5 (A/G)G(G/T)TCA] [67], suggesting that the
DNA binding properties of amphioxus and vertebrate
RAR/RXR heterodimers are highly conserved. Along
these lines, we found a similar, conserved DR5 RARE in
the regulatory region of a hemichordate CYP26 gene as
well as an equivalent DR2 RARE close to the CYP26
gene of a sea urchin. Whether these elements are recog-
nized by RAR/RXR heterodimers in these two species is
currently unknown. Their presence is nevertheless highly
suggestive of a biological function [13], which thus indi-
cates that direct regulation of CYP26 genes by RA sig-
naling is an ancestral feature that was already present in
the last common ancestor of all deuterostomes. In con-
trast, the lack of conserved RAREs in the regulatory re-
gions of the CYP26 genes of lophotrochozoans, which
generally encode RAR and RXR genes in their genomes
[2], support the notion that the direct regulation of
CYP26 transcription by RA signaling is not an ancestral
feature of bilaterian animals. This hypothesis is further
strengthened by the fact that RARs of gastropod mol-
lusks are unable to bind RA and hence to activate tran-
scription in its presence [68, 69].
The evolutionary history of CYP26 genes
In the animal kingdom, the basic molecular components
of the RA machinery have previously been described in
a wide variety of bilaterian animals, including both pro-
tostomes and deuterostomes [2, 45]. Genes encoding the
RA degrading enzyme CYP26 have, for example, been
identified in the genomes of priapulids, brachiopods,
mollusks, annelids, sea urchins, hemichordates, cephalo-
chordates, ascidian tunicates, and vertebrates, but not in
those of nematodes and arthropods, suggesting a sec-
ondary loss of CYP26 subfamily genes in these two ani-
mal lineages [2, 46]. We also found evidence for possible
secondary losses of CYP26 genes in different vertebrates,
including the lamprey P. marinus (lacking CYP26A1),
the chimera C. milii (lacking CYP26A1), the skate L. eri-
nacea (lacking CYP26C1), the coelacanth Latimeria
chalumnae (lacking CYP26C1), and the opossum Mono-
delphis domestica (lacking CYP26B1) (Additional files 1
and 2). Additional sequence information will be required
to validate the absence of these genes from their respect-
ive genomes and to assess, at which point in evolution
the confirmed gene losses occurred.
Our data further indicate that the evolutionary diversifi-
cation of the vertebrate CYP26 genes was a highly com-
plex process. Given the presence of at least one CYP26A1
and two CYP26B1/C1 genes in lampreys, the last common
ancestor of cyclostomes and gnathostomes probably
already possessed at least two CYP26 genes. Intriguingly,
in the lamprey L. japonicum, CYP26A1 and one of the two
CYP26B1/C1, CYP26B1/C1a, are physically linked in a
tandem cluster in the genome (on scaffold 19) (Additional
file 1), just like CYP26A1 and CYP26C1 in gnathostome
genomes [70]. This tandem cluster thus very likely origi-
nated before the cyclostome-gnathostome split, probably
by a tandem duplication event predating the vertebrate-
specific WGD. The two linked CYP26 genes were then
duplicated during the first WGD, which took place in the
basal vertebrate lineage before the cyclostome-
gnathostome split [71–73]. The subsequent loss of one of
the duplicated CYP26A1 genes yielded the CYP26 comple-
ment of extant lampreys, such as L. japonicum: one
CYP26A1 and two CYP26B1/C1 genes. In the gnathos-
tome lineage, additional duplications [71–73] resulted in
the diversification of CYP26B1 and CYP26C1 genes from
the ancestral CYP26B1/C1. Although requiring additional
scrutiny, this proposed scenario for vertebrate CYP26 di-
versification suggests that, if two rounds of WGD oc-
curred in the course of vertebrate evolution, the first likely
took place before and the second after the cyclostome-
gnathostome split [71, 72]. Alternatively, a single, ancient
WGD might have occurred before the cyclostome-
gnathostome split and was followed by independent seg-
mental duplications in the cyclostome and gnathostome
lineages [73]. Interestingly, in teleost fish, which under-
went an additional round of WGD [74], there are also only
three CYP26 genes, one member of each gnathostome
paralogy group (CYP26A1, CYP26B1, and CYP26C1), and
synteny analyses have revealed that the teleost-specific
CYP26 duplicates have been non-functionalized in the
course of evolution, in accordance with the DDC model
[30, 31, 70].
Our phylogenetic analyses also provided evidence that
CYP26 genes underwent multiple duplication events, not
only in vertebrates, but also in invertebrates, such as cepha-
lochordates, ascidian tunicates, hemichordates, mollusks,
annelids, brachiopods, and priapulids. Together, these re-
sults suggest that the ancestral bilaterian possessed a single
CYP26 gene that was subjected to independent duplication
events in different animal lineages. By correlating the tim-
ing of the lineage-specific duplications of invertebrate
CYP26 genes with the geological timescale, we observed
that the duplication events fall within three distinct time
periods, i.e. the late Ordovician, the early Carboniferous,
and the middle Permian/middle Triassic. Thus, the priapu-
lid CYP26 duplication took place during the late Ordovi-
cian, the first cephalochordate duplication and that
identified in the hemichordate S. kowalevskii in the early
Carboniferous, and the second cephalochordate duplication
and that in the hemichordate P.flava in the middle Per-
mian/middle Triassic. During the late Ordovician, a period
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marked by a mass extinction of marine species [75], earth
was characterized by a rising level of atmospheric O2 [76]
and by vast shallow and warm continental seas [75]. These
conditions were very favorable for the appearance of cyano-
bacterial mats at moderate depths of the water column [77,
78]. Similarly, during the early Carboniferous atmospheric
O2 levels were rising [76, 79], and the fossil record accounts
for one of the highest concentrations of calcified marine
cyanobacteria [78]. The middle Permian/middle Triassic, in
turn, saw the greatest biotic crisis in earth’s history [80],
and the fossil record suggests that, as a result of environ-
mental changes, cyanobacteria became one of the most
abundant life forms in both shallow and deep water envi-
ronments [81].
Extant cyanobacteria that are known to create massive
blooms under the exact same environmental conditions
include Trichodesmium, Anabaena, and Synechocystis
[82, 83], all of which are also known to produce high
levels of carotenoids and retinoids as anti-oxidative
byproducts, which have been shown to induce terato-
genic effects in the surrounding fauna [83–85]. The
prevalence of cyanobacterial mats in marine environ-
ments during the late Ordovician, early Carboniferous,
and the middle Permian/middle Triassic might thus ex-
plain why CYP26 duplications that occurred during
these two geological periods were independently
retained, by either neo- or sub-functionalization [30, 31],
in the genomes of different marine animal lineages. The
independent duplication of CYP26 genes might have in-
creased the overall fitness of a given population by favor-
ing individuals that were more efficient in buffering
fluctuations of exogenous retinoid levels. Altogether, this
finding represents an intriguing example of adaptive
convergent evolution in response to environmental
changes.
Conclusions
In the present study, we characterized the expression, func-
tion, and regulation of CYP26 genes during amphioxus de-
velopment. Our data suggest that, despite the independent
origins of the CYP26 gene repertoires in chordates, the
CYP26 genes of cephalochordates and vertebrates conver-
gently evolved similar developmental functions: RA-
dependent patterning and homeostatic regulation of RA
levels. Moreover, by comparing the regulatory regions of
CYP26 genes in three amphioxus species with those from
several different animal taxa, we identified a highly con-
served, functional RARE, suggesting that negative feedback
regulation of RA signaling is an evolutionary ancient mech-
anism for controlling endogenous RA levels. This mechan-
ism of regulation was likely already present in the last
common ancestor of all deuterostomes, but not in that of
all bilaterians. Finally, the correlation between the timing of
lineage-specific duplications of bilaterian CYP26 genes and
major environmental changes in the geological record sug-
gest that the evolutionary diversification of the CYP26 sub-
family in bilaterians was strongly influenced by
environmental pressures to buffer fluctuations of exogen-
ous retinoid levels. In sum, this work thus sheds light on
the evolution of the regulation of endogenous RA levels
and establishes a framework for studying adaptive conver-
gent evolutionary changes following gene duplication.
Methods
Amphioxus adult husbandry, embryo rearing, and
pharmacological treatments
Sexually mature animals of the European amphioxus
(Branchiostoma lanceolatum) were collected by dredging
in Argelès-sur-Mer, France, and retrieved from the sand
by sieving. The collected animals were split evenly into
tanks, with about 10–15 animals per aquarium, males
and females together. The water temperature in the
aquaria was kept at 16–17 °C, and the animals were kept
under a spring-like day/night period, with 14 h of light
and 10 h of absolute darkness. Spawning was induced by
a 36-h thermal shock at 23 °C, as previously described
[86–88]. Following oocyte and sperm collection and in
vitro fertilization, the embryos were raised in artificial
seawater, in the dark, at 19 °C [89]. Pharmacological
treatments of B. lanceolatum embryos were performed
at the late blastula stage (6 h of development) with all-
trans RA (at 0,1 μM and 1 μM) (Sigma-Aldrich, Saint-
Quentin Fallavier, France), the RAR antagonists BMS009
(at 1 μM) or BMS493 (at 1 μM) (Sigma-Aldrich, Saint-
Quentin Fallavier, France), the CYP26 inhibitor R115866
(at 0,5 μM and 0,1 μM) (provided by Janssen Research &
Development, a division of Janssen Pharmaceutica NV,
Beerse, Belgium) or with a combination of both BMS493
(at 1 μM) and R115866 (at 0,5 μM). All compounds were
initially dissolved in dimethyl sulfoxide (DMSO) to cre-
ate 1000X stock solutions and subsequently added to the
embryo cultures in artificial seawater in a 1:1000 dilution
to yield the respective final concentrations. As a control,
embryos were treated in separate dishes with DMSO
alone to a final dilution of 1:1000 [38, 39]. Puromycin
(Sigma-Aldrich, Saint-Quentin Fallavier, France) treat-
ments were performed at the mid neurula stage (19 h of
development) by adding the compound to embryo cul-
tures at a final concentration of 200 μg/ml. After 5 min
of incubation, all-trans RA (1 μM), the RAR antagonist
BMS009 (1 μM) or DMSO (at a dilution of 1:1000) were
added, and, 1 h thereafter, the embryos were frozen for
RNA extraction.
Sequence analyses and gene cloning
The B. lanceolatum CYP26-1, CYP26-2, and CYP26-3 se-
quences were obtained in silico from the B. lanceolatum
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genome by local BLAST using as template the sequences
of B. floridae and B. belcheri CYP26 (Additional file 1).
RNA was extracted from embryos at different develop-
mental stages according to the established protocols [90]
and cDNA was synthesized using the SuperScriptIII re-
verse transcription kit (Invitrogen, Cergy Pontoise,
France). Complete coding sequences of B. lanceolatum
CYP26-1, CYP26-2, and CYP26-3 were subsequently
cloned by PCR using gene-specific primers containing
the start and stop codons of the three CYP26 genes.
RACE-PCR experiments using the SMARTer™ RACE
cDNA amplification kit (Clontech, Saint-Germain-en-
Laye, France) were then performed to amplify the 5′ and
3′ untranslated regions (UTRs) of B. lanceolatum
CYP26-1, CYP26-2, and CYP26-3. The PCR and RACE-
PCR products were cloned into the pCRII-TOPO vector
(Invitrogen, Cergy Pontoise, France) and sequenced on
both strands for validation. The B. lanceolatum CYP26-
1, CYP26-2, and CYP26-3 sequences were deposited in
GenBank and their accession numbers are as follows:
CYP26-1 (KX118106), CYP26-2 (KX118108), and
CYP26-3 (KX118107). Furthermore, a 2291-bp piece of
the B. lanceolatum Rootletin gene was amplified by PCR,
cloned into the pGEM-T Easy vector (Promega, Charbon-
nières-les-Bains, France), and verified by sequencing on
both strands (GenBank accession number: KX118111),
before being used as a marker for in situ hybridization
(ISH) experiments.
Phylogenetic analyses
Phylogenetic trees of the CYP26 subfamily were calcu-
lated from amino acid and nucleotide sequences and the
sequences included in the analysis are listed in
Additional file 1, along with representative members of
the CYP51 subfamily, which were used as outgroup. Nu-
cleotide sequences were translated into amino acid se-
quences, aligned with Muscle as implemented in
SeaView v4.5.4 [91], and refined by eye (Additional file
5). The final amino acid alignment was subsequently
retransformed into the final nucleotide alignment
(Additional file 6). The best-fit models of amino acid
and nucleotide sequence evolution were selected based
on the AIC score implemented, respectively, in ProtTtest
3 [92] and jModelTest v2.1 [93]. Molecular phylogenies
were calculated with the Maximum Likelihood (ML)
method using PhyML v3.1 [94] under the models se-
lected by ProtTtest 3 (LG + I + G + F) and jModelTest
v2.1 (GTR + I + G). In addition, Bayesian Inference (BI)
analyses were performed using the program MrBayes
v3.2.6 [95] and the same models. The robustness of each
node was estimated by bootstrap analyses (in 1000 pseu-
doreplicates) using PhyML v3.1 for the ML tree and by
posterior probability for the BI tree, with two Monte Carlo
Markov Chain (MCMC) analyses run independently for
100 million generations and trees sampled every 1000
generations. The burn-in was determined with Tracer v1.6
[96], and the average standard deviation of split frequen-
cies remained at <0.05 after the burn-in threshold. 10%
and 50% of the trees were discarded, respectively, for the
amino acid and nucleotide datasets. Consensus trees were
visualized with Figtree v1.4 [97].
Comparative dating analysis
Based on the nucleotide dataset, the divergence dates of
the CYP26 sequences were estimated with Beast v2.4
[98] using divergence times in million years ago (Mya)
estimated with the calibration intervals proposed by
Benton and colleagues and dos Reis and colleagues [99,
100]: origin of Vertebrata (457,5-636,1 Mya), Euarchon-
toglires (61,6-164,6 Mya), and Hemichordata (504,5-
636,1 Mya) as well as the divergence between Holostei
and Teleostei (250,0–331,1 Mya) and between Otoce-
phala and Euteleostei (150,94–235 Mya). All calibration
constraint sets were defined following a hard minimum,
soft upper boundaries, and a lognormal prior [98].
Monte Carlo Markov Chain (MCMC) analyses were run
on the nucleotide dataset for 100 million generations
with trees sampled every 1000 generations [98]. Conver-
gence of the calculations was verified and burn-in esti-
mated with Tracer v1.6 [96]. The results of the MCMC
run were sampled with LogCombiner and a burn-in of
30% [98]. The trees were combined into a maximum
clade credibility tree using TreeAnnotator with an esti-
mation of the mean node height and highest posterior
density intervals fixed at 95% [98].
B. lanceolatum CYP26 cluster reconstitution and
identification of putative RAREs
The full-length ORFs of B. lanceolatum CYP26-1,
CYP26-2, and CYP26-3 were used as templates for local
BLAST searches of the B. lanceolatum genome to iden-
tify scaffolds containing UTRs and coding regions of
CYP26-1, CYP26-2, and CYP26-3. Sequences of genome
regions not obtained by these BLAST approaches (hence
corresponding to gaps in the B. lanceolatum CYP26
cluster) were subsequently identified by reciprocal
BLAST searches of the B. lanceolatum genome sequence
using short regions (less than 2 Kbp) of the B. floridae
and B. belcheri CYP26 clusters. Putative RARE se-
quences were identified with an automated pipeline [51]
using as input RAREs previously described as functional
in amphioxus as well as all possible RARE combinations
resulting from the canonical vertebrate RARE consensus:
(A/G)G(G/T)TCA(N)0–9(A/G)G(G/T)TCA. Detailed se-
quence and scaffold information is provided in Add-
itional files 4 and 7.
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Multiple expectation maximization algorithm for motif
elicitation (MEME) analysis
Multiple expectation maximization algorithm for motif
elicitation (MEME) logos were calculated with MEME
Suite v4.10.1 [101] using as input file the sequences of
the in vitro validated B. lanceolatum DR5 RARE se-
quences including 5 nucleotides upstream and down-
stream of the element. The following settings were used
to obtain the MEME logos: nmotifs = 2, minwidth = 15,
maxwidth = 27.
Electrophoretic mobility shift assay (EMSA) experiments
The B. lanceolatum RAR and RXR coding sequences
were amplified by PCR and cloned into the pGEM-T
Easy vector (Promega, Charbonnières-les-Bains, France).
Subcloning into the pCS2+ vector [102] was performed
using introduced EcoRI and XhoI restriction sites. Fol-
lowing verification by sequencing on both strands of the
RAR-pCS2+ and RXR-pCS2+ constructs (GenBank ac-
cession numbers: B. lanceolatum RAR, KX118109; B.
lanceolatum RXR, KX118110), RAR and RXR proteins
were produced by in vitro translation using the TNT
coupled reticulocyte lysate system (Promega, Charbon-
nières-les-Bains, France). Electrophoretic mobility shift
assays (EMSAs) were performed as previously described
[69] using 4 μl of each receptor synthesized in vitro and
30–50 × 103 CPM of double-stranded oligonucleotide
probe end-labeled with (γ-32P)ATP, incubated for 30 min
on ice in a final volume of 20 μl of binding buffer:
20 mM Tris–HCl pH8, 50 mM KCl, 2 mM DTT,
25 mM MgCl2, 50 mM NaCl, 1 μg poly (dI-dC), and
10% glycerol. The samples were subsequently run on a
5% native acrylamide gel in 1X TAE for 2 h.
In situ hybridization (ISH), histology, imaging, and tail fin
measurements
Antisense riboprobe synthesis, ISH, and Hoechst stain-
ing (Invitrogen, Cergy Pontoise, France) experiments
were performed as previously described [103]. For ISH,
Hoechst staining, and tail fin measurements, amphioxus
(B. lanceolatum) embryos and larvae were fixed in 4%
paraformaldehyde at different developmental stages, as
previously described [103]. Following ISH, B. lanceola-
tum embryos and larvae were first photographed as
whole mounts using Zeiss DIC (differential interference
contrast) optics (Carl Zeiss SAS, Marly le Roi, France)
and subsequently counterstained in Ponceau S (Sigma-
Aldrich, Saint-Quentin Fallavier, France), embedded in
Spurr’s resin (Sigma-Aldrich, Saint-Quentin Fallavier,
France), and prepared as 3 μm sections for light micros-
copy observations and photography. Following Hoechst
staining, B. lanceolatum larvae were embedded in
Mowiol mounting medium (Sigma-Aldrich, Saint-
Quentin Fallavier, France) overnight at 4 °C, before being
imaged using a Leica TCS SP5 confocal microscope
(Leica Microsystems SAS, Nanterre, France). ImageJ was
subsequently used for image processing and for the cre-
ation of maximal projections [104]. For tail fin measure-
ments, normal and treated B. lanceolatum larvae were
photographed using Zeiss DIC optics (Carl Zeiss SAS,
Marly le Roi, France). The length of the tail fin, defined
as the distance between the anterior-most end of the tail
fin ectoderm and the posterior-most tip of the tail fin
(as represented in Fig. 3g), was subsequently measured
using the measurement tool of ImageJ [104] and ultim-
ately represented as mean ± standard deviation, with n =
15 for each treatment and control conditions. Student’s
t-test was used to assess the statistical significance of the
length differences measured in the treated specimens
relative to the DMSO control.
Quantitative real time PCR (qPCR) assays
Quantitative real time PCR (qPCR) experiments were
performed at two developmental stages (mid neurula at
20 h of development and early larva at 48 h of develop-
ment). In addition to the puromycin-treated material de-
scribed above, the cDNAs from DMSO treatment
controls as well as from embryos treated at the late blas-
tula stage (6 h of development) with either 1 μM all-
trans RA or 1 μM of the RAR antagonist BMS009 were
assayed on a MJ Research DNA Engine Opticon system
(Bio-Rad, Marnes-la-Coquette, France) using the Quan-
tiTect SYBR Green PCR reagent (Qiagen SAS, Courta-
boeuf, France) and primers specific for B. lanceolatum
CYP26-1, CYP26-2, CYP26-3, RAR, and 18S rRNA (Add-
itional file 8). Based on the lack of response to the differ-
ent pharmacological treatments assayed, 18S rRNA was
selected as the reference for internal standardization of
the starting quantity of RNA. Each qPCR experiment
was performed in triplicates and the relative expression
was normalized to RAR or CYP26-2 expression levels, in
Figs. 4 and 6, respectively. Normalized expression levels
are shown as ΔΔCT means ± standard deviation, with n
= 3. Furthermore, fold change of expression relative to
the control is represented as the mean of the ΔΔCT ra-
tios of all possible combinations of the three replicates
of a given condition over the three controls ± standard
deviation, with n = 9.
Additional files
Additional file 1: Accession numbers of the CYP26 and CYP51 subfamily
sequences used to calculate the phylogenetic trees and to carry out the
dating analyses. Species names and database information are provided
for each sequence. (XLSX 12 kb)
Additional file 2: Phylogenetic tree of the CYP26 subfamily, with CYP51
as outgroup. Tree calculated with the Bayesian Inference (BI) and
Maximum Likelihood (ML) methods based on 15 vertebrate species (42
CYP26 sequences), 1 tunicate species (2 CYP26 sequences), 3
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cephalochordate species (9 CYP26 sequences), 3 ambulacrarian species (6
CYP26 sequences), 5 lophotrochozoan species (12 CYP26 sequences), and
1 ecdysozoan species (2 CYP26 sequences) (for details see Additional file
1). The robustness of each node was assessed by posterior probability
(for the BI phylogeny) and bootstrap (for the ML phylogeny) analyses,
which are indicated at each node: posterior probabilities (ranging from 0
to 1)/bootstrap percentages (ranging from 0 to 100). “–” indicates nodes
where the ML tree did not recover the branching pattern of the BI tree
or nodes with bootstrap support inferior to 50%. Branch lengths are
representative of the amino acid substitution rate. Species name
abbreviations: B.b., Branchiostoma belcheri (in blue); B.f., Branchiostoma
floridae (in red); B.l., Branchiostoma lanceolatum (in green); C.g.,
Crassostrea gigas; C.i., Ciona intestinalis; C.m., Callorhinchus milii; C.t.,
Capitella teleta; D.r., Danio rerio; G.a., Gasterosteus aculeatus; G.g., Gallus
gallus; H.s., Homo sapiens; L.a. Lingula anatina; L.c., Latimeria chalumnae;
L.e., Leucoraja erinacea; L.g., Lottia gigantea; L.j., Lethenteron japonicum;
L.o., Lepisosteus oculatus; M.d., Monodelphis domestica; M.m., Mus
musculus; O.b., Octopus bimaculoides; O.l., Oryzias latipes; P.c., Priapulus
caudatus; P.f., Ptychodera flava; P.m., Petromyzon marinus; S.k., Saccoglossus
kowalevskii; S.p., Strongylocentrotus purpuratus; T.r., Takifugu rubripes; X.t.,
Xenopus tropicalis. (PDF 559 kb)
Additional file 3: Comparative dating tree for the CYP26 subfamily.
Divergence dates of the CYP26 sequences were estimated using fossil-
based calibration intervals. Cladogram node dates represent estimation of
the mean node height and the highest posterior density intervals fixed at
95% are shown in parentheses. Geological era abbreviations: Cam,
Cambrian; Car, Carboniferous; Cre, Cretaceous; Dev, Devonian; Jur,
Jurassic; Ord, Ordovician; Per, Permian; Sil, Silurian; Tri, Triassic. Species name
abbreviations: B.b., Branchiostoma belcheri (in blue); B.f., Branchiostoma
floridae (in red); B.l., Branchiostoma lanceolatum (in green); C.g., Crassostrea
gigas; C.i., Ciona intestinalis; C.m., Callorhinchus milii; C.t., Capitella teleta; D.r.,
Danio rerio; G.a., Gasterosteus aculeatus; G.g., Gallus gallus; H.s., Homo sapiens;
L.a. Lingula anatina; L.c., Latimeria chalumnae; L.e., Leucoraja erinacea; L.g.,
Lottia gigantea; L.j., Lethenteron japonicum; L.o., Lepisosteus oculatus; M.d.,
Monodelphis domestica; M.m., Mus musculus; O.b., Octopus bimaculoides; O.l.,
Oryzias latipes; P.c., Priapulus caudatus; P.f., Ptychodera flava; P.m., Petromyzon
marinus; S.k., Saccoglossus kowalevskii; S.p., Strongylocentrotus purpuratus; T.r.,
Takifugu rubripes; X.t., Xenopus tropicalis. (PDF 271 kb)
Additional file 4: Conserved retinoic acid response elements (RAREs)
found in the Branchiostoma lanceolatum, Branchiostoma belcheri, and
Branchiostoma floridae CYP26 clusters. B. lanceolatum RAREs recognized
and bound by the B. lanceolatum RAR/RXR heterodimer in vitro (Fig. 8)
are indicated in black, RAREs that do not associate with the B.
lanceolatum RAR/RXR heterodimer in vitro are shown in grey. The in vitro
validated B. lanceolatum RAREs composed of two direct repeats (DRs)
and separated by a 5 nucleotide spacer (i.e. the validated B. lanceolatum
DR5-type RAREs) were used to calculate a consensus B. lanceolatum DR5
RARE by multiple expectation maximization algorithm for motif elicitation
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